Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-207792
Filing Date
2013-05-08
Accepted
2013-05-08 17:10:20
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d501543d10q.htm 10-Q 321526
2 EX-31.1 d501543dex311.htm EX-31.1 7279
3 EX-31.2 d501543dex312.htm EX-31.2 7261
4 EX-32.1 d501543dex321.htm EX-32.1 4467
5 EX-32.2 d501543dex322.htm EX-32.2 4454
  Complete submission text file 0001193125-13-207792.txt   2697018

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnov-20130331.xml EX-101.INS 251650
7 XBRL TAXONOMY EXTENSION SCHEMA mnov-20130331.xsd EX-101.SCH 31391
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20130331_cal.xml EX-101.CAL 47033
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20130331_def.xml EX-101.DEF 188756
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20130331_lab.xml EX-101.LAB 271855
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20130331_pre.xml EX-101.PRE 221407
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 950 SAN DIEGO CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 950 SAN DIEGO CA 92122 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 13825430
SIC: 2834 Pharmaceutical Preparations